Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

4.120 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

23 24 Next >

Where Will Recursion Pharmaceuticals Be in 5 Years? ↗

April 17, 2024

A lot is riding on whether its platform is valuable, or vaporware.

Via The Motley Fool

Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer

April 16, 2024

Dr. Khan, formerly the Chief Data Science Officer and Global Head of Strategy and Portfolio, Innovative Medicine R&D at Johnson & Johnson (J&J), will also join Recursion’s Board of Directors

From Recursion Pharmaceuticals, Inc.

Via GlobeNewswire

Biotech on a Budget: 7 Stocks Under $10 With Huge Potential ↗

April 15, 2024

With the medical care industry always liable for negative surprises, you might as well go for big upside with under-$10 biotech stocks.

Via InvestorPlace

Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for April 2024 ↗

April 15, 2024

Through opportunity for growth and strong financial performance, these three Cathie Wood stocks could provide generous returns.

Via InvestorPlace

Analyst Scoreboard: 5 Ratings For Recursion Pharmaceuticals ↗

April 09, 2024

Via Benzinga

Forecasting The Future: 4 Analyst Projections For Recursion Pharmaceuticals ↗

March 04, 2024

Via Benzinga

The 10 Stocks In The Clinical-Stage BioTech Drug Stocks Index Are Down 4% YTD ↗

April 15, 2024

The pharmaceutical industry is embracing AI to streamline drug discovery and researching the use of psychedelic compound-based ingredients for the treatment of, as yet, untreatable diseases.

Via Talk Markets

Topics Artificial Intelligence

Cathie Wood's Ark Invest Sells $20M+ Coinbase Shares As Bitcoin Trades Over $70K, Buys Palantir, Sells Nvidia Stock ↗

April 11, 2024

On Thursday, Cathie Wood’s Ark Invest made significant trades involving Coinbase Global, Inc. (NASDAQ:COIN), Palantir Technologies Inc. (NYSE:PLTR), and Nvidia Corp.

Via Benzinga

Can Recursion Pharmaceuticals Stock Double in 5 Years? Here's What It Would Take. ↗

April 10, 2024

Recursion is playing the long game with its AI-focused approach to drug discovery and development.

Via The Motley Fool

The AI Advantage: 2 Healthcare Stocks at the Forefront of Innovation ↗

April 08, 2024

They might not be profitable yet, but they're swinging for the fences.

Via The Motley Fool

Topics Artificial Intelligence

AI Surge Ending: Only One Category Was Up This Week ↗

April 06, 2024

Six of the 7 categories we cover dropped this week, compared with 3 in March. The data clearly indicates that the surge in this sector is stalling or perhaps is even over.

Via Talk Markets

Topics Artificial Intelligence

Is This Under-the-Radar Artificial Intelligence (AI) Stock a Buy? ↗

April 04, 2024

This stock's upside is huge, but so is its downside.

Via The Motley Fool

Topics Artificial Intelligence

Recursion to Participate in Upcoming Investor Conference

April 02, 2024

From Recursion Pharmaceuticals

Via GlobeNewswire

AI Sector Stalling: Only 4 Of 7 Categories Went Up In March ↗

March 31, 2024

No AI category went down in February, but 3 did in March - confirming my comment last week that

Via Talk Markets

Topics Artificial Intelligence

Cathie Wood's Ark Invest Continues To Double Down On Moderna, Sells Nvidia Shares ↗

March 26, 2024

Via Benzinga

Recursion Publishes Annual Environmental, Social and Governance Report

March 26, 2024

Provides progress updates in support of long-term commitments focused on reducing greenhouse gas emissions, improving workforce diversity and accelerating community impact.

From Recursion Pharmaceuticals

Via GlobeNewswire

Nvidia's AI Revolution Is Transforming Healthcare with Johnson & Johnson and GE Healthcare Partnerships ↗

March 25, 2024

Nvidia announces partnerships with J&J and GE Healthcare to integrate generative AI into surgery and medical imaging at GTC AI conference. Analysts see potential for revenue growth outside tech sector....

Via Benzinga

Topics Artificial Intelligence

New COVID-Like Outbreak 'Matter Of When, Not If,' WHO Director Warns As Scientists Race To Prepare Using Artificial Intelligence ↗

March 18, 2024

Via Benzinga

Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 13, 2024

Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24...

Via Benzinga

Nvidia's Secret Weapon Is Not Just Chips But Investing $1.5B In AI's Rising Stars: Report Unveils CEO Jensen Huang's 10-Year Vision ↗

March 11, 2024

Additionally, the investments help Nvidia "build out the future ecosystem of businesses that depend on its technology" even as rivals are trying to break into the chipmaker's dominance.

Via Benzinga

Topics Artificial Intelligence

Recursion Announces Plans to Open New Office in London

March 11, 2024

Appoints Michael Bronstein as Scientific Advisor and launches recruiting effort to fill the first 20 open roles across technology and biology, establishing a hub for world-class TechBio talent in the...

From Recursion Pharmaceuticals, Inc.

Via GlobeNewswire

Recursion Pharmaceuticals Stock Has 33% Upside, According to 1 Wall Street Analyst ↗

March 07, 2024

The company just made a provocative move in one of its collaborations.

Via The Motley Fool

The Top 7 Small-Cap Stocks to Buy in March 2024 ↗

March 04, 2024

These top small-cap stocks to buy are set for a strong 2024 as reduced inflation increases their growth prospects.

Via InvestorPlace

Topics Economy

The Top 3 Healthcare Stocks to Buy on Weakness in 2024 ↗

March 04, 2024

Many healthcare stocks have extremely bright outlooks and very low valuations. Here are three top healthcare stocks to buy.

Via InvestorPlace

AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD ↗

March 04, 2024

Grand View Research says the global

Via Talk Markets

Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community

March 01, 2024

From Recursion Pharmaceuticals

Via GlobeNewswire

Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too? ↗

March 01, 2024

On the leading edge of rare disease treatment and therapy is where you will find these Cathie Wood biotech stocks.

Via InvestorPlace

Recursion to Participate in Upcoming Investor Conferences

March 01, 2024

From Recursion Pharmaceuticals

Via GlobeNewswire

Why Recursion Pharmaceuticals Stock Dived by Nearly 17% Today ↗

February 28, 2024

The company had attracted much interest due to its heavy use of artificial intelligence, but its latest fundamentals disappointed many.

Via The Motley Fool

Topics Artificial Intelligence

Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 28, 2024

Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.